Cardiac Issues Associated with High-Dose Drug Trial

Last week, Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced they were ending the higher-dose portions of two multiple-sclerosis medication studies. The decision came after eight patients suffered nonfatal… Read More

How Competition is Affecting Big Pharma

Although pharmaceutical companies have seen an improvement in drug pipelines, they are facing a new challenge. Namely, the first generation of blockbuster biological drugs manufactured by giants Bristol-Myers Squib, Eli… Read More